70 related articles for article (PubMed ID: 38627808)
1. Safety and efficacy of combined resection of colorectal peritoneal and liver metastases.
Downs-Canner S; Shuai Y; Ramalingam L; Pingpank JF; Holtzman MP; Zeh HJ; Bartlett DL; Choudry HA
J Surg Res; 2017 Nov; 219():194-201. PubMed ID: 29078882
[TBL] [Abstract][Full Text] [Related]
2. Invited commentary: Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
Pocard M
World J Surg; 2024 Apr; 48(4):879-880. PubMed ID: 38447984
[No Abstract] [Full Text] [Related]
3. Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review.
Sarofim M; Wijayawardana R; Ahmadi N; Morris DL
World J Surg Oncol; 2024 Apr; 22(1):99. PubMed ID: 38627808
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Stable Lung Colorectal Metastases on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Pantelis A; Ben-Yaacov A; Adileh M; Schtrechman G; Shacham-Shmueli E; Boursi B; Margalit O; Halpern N; Mor E; Assaf D; Maximiliano K; Nissan A; Laks S
J Gastrointest Surg; 2022 Aug; 26(8):1724-1731. PubMed ID: 35768716
[TBL] [Abstract][Full Text] [Related]
5. Patterns and Timing of Recurrence following CRS and HIPEC in Colorectal Cancer Peritoneal Metastasis.
Hassan S; Malcomson L; Soh YJ; Wilson MS; Clouston H; O'Dwyer ST; Kochhar R; Aziz O
Eur J Surg Oncol; 2023 Jan; 49(1):202-208. PubMed ID: 35987797
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis.
Narasimhan V; Tan S; Kong J; Pham T; Michael M; Ramsay R; Warrier S; Heriot A
Colorectal Dis; 2020 Nov; 22(11):1482-1495. PubMed ID: 32027455
[TBL] [Abstract][Full Text] [Related]
7. Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A systematic review and discussion of latest controversies.
Flood M; Narasimhan V; Waters P; Ramsay R; Michael M; Warrier S; Heriot A
Surgeon; 2021 Oct; 19(5):310-320. PubMed ID: 33023847
[TBL] [Abstract][Full Text] [Related]
8. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351
[No Abstract] [Full Text] [Related]
9. The quest for excellence in surgical research.
Sarofim M
Surgeon; 2023 Dec; 21(6):e303-e304. PubMed ID: 37802705
[No Abstract] [Full Text] [Related]
10. Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer: A Phase 3 Randomized Clinical Trial.
Arjona-Sánchez A; Espinosa-Redondo E; Gutiérrez-Calvo A; Segura-Sampedro JJ; Pérez-Viejo E; Concepción-Martín V; Sánchez-García S; García-Fadrique A; Prieto-Nieto I; Barrios-Sanchez P; Torres-Melero J; Ramírez Faraco M; Prada-Villaverde A; Carrasco-Campos J; Artiles-Armas M; Villarejo-Campos P; Ortega-Pérez G; Boldo-Roda E; Sánchez-Hidalgo JM; Casado-Adam A; Rodríguez-Ortiz L; Aranda E; Cano-Osuna MT; Díaz-López C; Romero-Ruiz A; Briceño-Delgado J; Rufián-Peña S;
JAMA Surg; 2023 Jul; 158(7):683-691. PubMed ID: 37099280
[TBL] [Abstract][Full Text] [Related]
11. Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence.
Pasqual EM; Londero AP; Robella M; Tonello M; Sommariva A; De Simone M; Bacchetti S; Baiocchi G; Asero S; Coccolini F; De Cian F; Guaglio M; Cinquegrana A; Cenzi C; Scaringi S; Macrì A
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765565
[TBL] [Abstract][Full Text] [Related]
12. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.
Morgan E; Arnold M; Gini A; Lorenzoni V; Cabasag CJ; Laversanne M; Vignat J; Ferlay J; Murphy N; Bray F
Gut; 2023 Feb; 72(2):338-344. PubMed ID: 36604116
[TBL] [Abstract][Full Text] [Related]
13. Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature.
Erali RA; Forsythe SD; Gironda DJ; Schaaf CR; Wajih N; Soker S; Votanopoulos KI
J Gastrointest Cancer; 2023 Sep; 54(3):712-719. PubMed ID: 36447085
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
